|Bid||160.82 x 1100|
|Ask||160.89 x 900|
|Day's range||160.72 - 162.10|
|52-week range||123.57 - 164.13|
|Beta (5Y monthly)||0.88|
|PE ratio (TTM)||134.14|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV) has been named to FORTUNE magazine’s "World’s Most Admired Companies" list. IQVIA has received this distinction every year, since its inception, following the merger between IMS Health and Quintiles in 2016. IQVIA is recognized in FORTUNE’s Healthcare: Pharmacy and Other Services category with high marks regarding efficient use of corporate assets, management quality, effectiveness in conducting business globally, and long-term investment value.
IQVIA™ (NYSE: IQV) today announced that AstraZeneca (LON: AZN) has selected IQVIA Technologies’ Orchestrated Customer Engagement (OCE) platform to further its digital agenda and establish its "Field of the Future."
Martin Marietta Materials, Inc. (MLM) today announced the appointment of Thomas (Tom) H. Pike as an independent member to its Board of Directors, effective July 15, 2019. With Mr. Pike’s appointment, the Martin Marietta Board is comprised of 10 directors, five of whom have joined since 2016. Mr. Pike will serve on Martin Marietta’s Management Development and Compensation Committee.
HENDERSON, Nev., April 24, 2019 -- United Health Products, Inc. (OTC: UEEC), (“UHP” or “the company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for.
NEW YORK, March 05, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
NEW YORK, Feb. 08, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.